DPP-4 inhibitors and angioedema: a cause for concern?

被引：16
|
作者：
Byrd, Jennifer S. [2 ]
Minor, Deborah S. [1 ]
Elsayed, Raghda [3 ]
Marshall, Gallen D.
机构：
[1] Univ Mississippi, Med Ctr, Dept Med, Div Gen Internal Med Hypertens, Jackson, MS 39216 USA
[2] Univ Mississippi, Med Ctr, Dept Pharm, Jackson, MS 39216 USA
[3] Providence Med Grp, Portland, OR USA
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2011年 / 106卷 / 05期
关键词：
DIPEPTIDYL PEPTIDASE-IV; RISK; SITAGLIPTIN; BRADYKININ; EFFICACY; EDEMA;
D O I：
10.1016/j.anai.2011.02.012
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：436 / 438
页数：3
相关论文
共 50 条
  • [41] DPP-4 Inhibitors-Renoprotection in Diabetic Nephropathy?
    Panchapakesan, Usha
    Pollock, Carol A.
    DIABETES, 2014, 63 (06) : 1829 - 1830
  • [42] DPP-4 inhibitors associated with acute kidney injury
    Reactions Weekly, 2016, 1605 (1) : 8 - 8
  • [43] Case study DPP-4 Inhibitors and Insulin in Combination
    Holstein, Andreas
    DIABETES STOFFWECHSEL UND HERZ, 2012, 21 (03): : 165 - 170
  • [44] DPP-4 inhibitors have differing AE trends
    Reactions Weekly, 2023, 1940 (1) : 9 - 9
  • [45] Alogliptin: a new addition to the class of DPP-4 inhibitors
    Andukuri, Radha
    Drincic, Andjela
    Rendell, Marc
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2009, 2 : 117 - 126
  • [46] The physiology of incretin hormones and the basis for DPP-4 Inhibitors
    McKennon, Skye Aiko
    Campbell, R. Keith
    DIABETES EDUCATOR, 2007, 33 (01): : 55 - +
  • [47] DPP-4 inhibitors: a new class of oral antidiabetics
    Gallwitz, B.
    DIABETES STOFFWECHSEL UND HERZ, 2007, 16 (01): : 43 - 50
  • [48] DPP-4 inhibitors: pharmacological differences and their clinical implications
    Ceriello, Antonio
    Sportiello, Liberata
    Rafaniello, Concetta
    Rossi, Francesco
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 : S57 - S68
  • [49] DPP-4 inhibitors in the treatment of type 2 diabetes
    Duez, Helene
    Cariou, Bertrand
    Staels, Bart
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (07) : 823 - 832
  • [50] No risk of GI obstruction with DPP-4 inhibitors (gliptins)
    Reactions Weekly, 2016, 1629 (1) : 4 - 4
12345